Novo Nordisk - ADR

NYSE:NVO   3:59:56 PM EDT
96.41
+0.09 (+0.09%)
4:00:00 PM EDT: $96.42 +0.01 (+0.01%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)168.17B
Current PE3.64
Forward PE 30.61
2yr Forward PE 27.78
See more stats
Estimates Current Quarter
Revenue$5.77 Billion
Adjusted EPS$0.72
See more estimates
10-Day MA$100.93
50-Day MA$109.16
200-Day MA$94.80
See more pivots

Novo Nordisk - ADR Stock, NYSE:NVO

Novo All?©, Novo All?©, Bagsv??rd, Capital Region 2880
Phone: +45.44.44.88.88
Number of Employees: 45323

Description

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsv??rd, Denmark.